BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koudriavtseva T, Plantone D, Renna R, Mandoj C, Giannarelli D, Mainero C. Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients. Neurol Sci 2015;36:2263-8. [DOI: 10.1007/s10072-015-2348-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Koudriavtseva T. Commentary: Acute Hemorrhagic Leukoencephalitis (Weston-Hurst Syndrome) in a Patient with Relapse-Remitting Multiple Sclerosis. Front Immunol 2016;7:207. [PMID: 27252706 DOI: 10.3389/fimmu.2016.00207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Reynolds JA, Briggs TA, Rice GI, Darmalinggam S, Bondet V, Bruce E, Khan M, Haque S, Chinoy H, Herrick AL, McCarthy EM, Zeef L, Hayes A, Duffy D, Parker B, Bruce IN. Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. Arthritis Res Ther 2019;21:147. [PMID: 31200750 DOI: 10.1186/s13075-019-1929-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
3 Georgakopoulou VE, Lembessis P, Skarlis C, Gkoufa A, Sipsas NV, Mavragani CP. Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes. Front Med 2022;9:850472. [DOI: 10.3389/fmed.2022.850472] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Miller JM, Beales JT, Montierth MD, Briggs FB, Frodsham SF, Davis MF. The Impact of Multiple Sclerosis Disease Status and Subtype on Hematological Profile. Int J Environ Res Public Health 2021;18:3318. [PMID: 33807004 DOI: 10.3390/ijerph18063318] [Reference Citation Analysis]
5 Di Donato I, Federico A. Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016). Neurol Sci 2017;38:9-18. [PMID: 28093657 DOI: 10.1007/s10072-017-2815-y] [Reference Citation Analysis]
6 Doskas T, Dardiotis E, Vavougios GD, Ntoskas KT, Sionidou P, Vadikolias K. Stroke risk in multiple sclerosis: a critical appraisal of the literature. International Journal of Neuroscience. [DOI: 10.1080/00207454.2022.2056459] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Newman JM, Naziri Q, Chughtai M, Khlopas A, Kryzak TJ, Navale SM, Higuera CA, Mont MA. Does Multiple Sclerosis Affect the Inpatient Perioperative Outcomes After Total Hip Arthroplasty? The Journal of Arthroplasty 2017;32:3669-74. [DOI: 10.1016/j.arth.2017.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]